Holdings (36)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 7.88% |
| Max Healthcare Institute Ltd. | Healthcare | Equity | 5.87% |
| Abbott India Ltd. | Healthcare | Equity | 5.48% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 5.01% |
| Healthcare Global Enterprises Ltd. | Healthcare | Equity | 4.84% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.76% |
| Cipla Ltd. | Healthcare | Equity | 4.14% |
| Rainbow Children's Medicare Ltd. | Healthcare | Equity | 3.77% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 3.72% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 3.52% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | -1.21% | 22.38% | 16.22% | 9.22% |
| Category Average | -2.14% | 22.11% | 14.61% | NA% |
| Rank Within Category | 13.00% | 4.00% | 3.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 0.72%
Inclusive of GST
Exit load
Exit load of 0.25% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Experience
Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services